{"organizations": [], "uuid": "4b06adf35f028ea0ca4d9ea40bef524db6c60653", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biotest-fy-revenue-falls-to-eur-37/brief-biotest-fy-revenue-falls-to-eur-378-1-mln-on-recall-of-human-albumin-idUSASM000JSF", "country": "US", "domain_rank": 408, "title": "BRIEF-Biotest FY Revenue Falls To EUR 378.1 Mln On Recall Of Human Albumin", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-02-27T17:35:00.000+02:00", "replies_count": 0, "uuid": "4b06adf35f028ea0ca4d9ea40bef524db6c60653"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biotest-fy-revenue-falls-to-eur-37/brief-biotest-fy-revenue-falls-to-eur-378-1-mln-on-recall-of-human-albumin-idUSASM000JSF", "ord_in_thread": 0, "title": "BRIEF-Biotest FY Revenue Falls To EUR 378.1 Mln On Recall Of Human Albumin", "locations": [], "entities": {"persons": [{"name": "biotest", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biotest ag", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - BIOTEST AG:\n* DGAP-ADHOC: BIOTEST AG: BIOTEST REACHES FY 2017 EBIT GUIDANCE\n* FY REVENUE 378.1 MILLION EUR * MAIN REASON FOR DECLINE IN REVENUE WAS RECALL OF HUMAN ALBUMIN\n* FY EBIT GUIDANCE WAS REACHED WITH EUR 18 MILLION * 2017 REVENUE OF EUR 378.1 MILLION IN CONTINUING OPERATIONS, COMPARED TO EUR 408.0 MILLION IN PREVIOUS YEARâ€‹\n* ONE-OFF EXPENSES IN AMOUNT OF EUR 37.7 MILLION HAD A NEGATIVE IMPACT ON EBIT OF CONTINUING OPERATIONS\n* EBIT IN CONTINUING OPERATIONS AMOUNTED TO EUR -9.3 MILLION IN 2017 AFTER EUR 35.2 MILLION IN PREVIOUS YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T17:35:00.000+02:00", "crawled": "2018-02-28T12:46:53.050+02:00", "highlightTitle": ""}